Therapy News and Research

RSS

Early treatment with pharmacological therapy may reduce hypertension

Patients experiencing high normal blood pressure (HNBP), a precursor to hypertension, may benefit from early treatment with pharmacological therapy, according to new research presented at the American College of Cardiology's 55th Annual Scientific Session.

20 Mar 2006

Atorvastatin could prove an effective therapy for multiple sclerosis

Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).

20 Mar 2006

Diabetics benefit less from anti-hypertensive treatment to reduce enlarged heart

Standard blood-pressure-lowering treatment to reduce dangerously enlarged hearts is much less effective and less beneficial in diabetic vs. nondiabetic patients, a team led by NewYork-Presbyterian Hospital/Weill Cornell Medical Center researchers reports in this month's issue of Circulation.

20 Mar 2006

Carotid stenting beneficial for patients with disease but no symptoms

Results from the largest-ever multi-center U.S. registry on the efficacy of carotid stenting shows that the procedure is safe in patients who are at high risk for standard surgical therapy.

20 Mar 2006

Long-term treatment effective in preventing future depressive episodes

People age 70 and older who continued taking the antidepressant that helped them to initially recover from their first episode of depression were 60 percent less likely to experience a new episode of depression over a two-year study period than those who stopped taking the medication

20 Mar 2006

Hypertension reduced with early intervention

Treating pre-hypertension with medication and lifestyle modifications reduces the risk of patients progressing to hypertension, a new study involving researchers at UT Southwestern Medical Center has concluded.

19 Mar 2006

Study offers piece of missing link needed in understanding receptor function possibly providing safe, ethical source for replacing brain cells

Japanese researchers have found a piece of the "missing link" about how bone marrow stromal cells restore lost neurologic function when transplanted into animals exhibiting central nervous system disorders, according to a study in the March issue of the Journal of Nuclear Medicine.

19 Mar 2006

Orthodontics can make kids feel better about themselves

Orthodontics are often necessary to help improve the stability, function, and health of an individual's teeth; otherwise, many people would be at higher risk for gum disease, tooth decay, and tooth loss because of improper teeth positioning in their mouth

19 Mar 2006

Salmonella research provides clues to antibiotic development

Pathogens are becoming increasingly resistant to antibiotics, causing problems for therapy. Doctors need to have antibiotics available that work in new kinds of ways.

19 Mar 2006

Ginseng may improve survival and quality of life after a diagnosis of breast cancer

Ginseng, one of the most widely used herbs in traditional Chinese medicine, may improve survival and quality of life after a diagnosis of breast cancer, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.

19 Mar 2006

Neuroscience Therapy unveils new Electro Stimulation Device

Neuroscience Therapy Corp. has unveiled its leading product: P-Stim Electro Stimulation Device.

17 Mar 2006

FDA grants Cerexa fast track designation

Cerexa has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PPI-0903, a next-generation, broad-spectrum, cephalosporin antibiotic, for the treatment of complicated skin and skin structure infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA).

17 Mar 2006

African American women urged to confront colorectal cancer

Despite having the greatest risk of developing and dying from colorectal cancer (CRC) of any gender, race or ethnicity, an astounding 96 percent of African American women do not consider themselves to be at high risk for the disease, according to a new Harris poll.

17 Mar 2006

Drug trial nightmare - two still critically ill

In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.

17 Mar 2006

Low PSA score after radiation can predict prostate cancer return

A consortium of prostate cancer experts have discovered, through a clinical investigation, that prostate cancer patients who have a lower prostate specific antigen (PSA) score after radiation therapy to treat their cancer are less likely to have their prostate cancer return or spread to other parts of their body than patients with a higher PSA score.

15 Mar 2006

New model is able to accurately predict survival for patients with heart failure

A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.

15 Mar 2006

Study explains how brain cells die in patients with Alzheimer's Disease

Researchers at Children's Hospital & Research Center at Oakland (CHRCO) have published a new study that is the first to explain how brain cells die in patients with Alzheimer's Disease.

15 Mar 2006

Fondaparinux significantly reduces risk of death for heart attack patients

Heart attack patients who have a certain pattern on an electrocardiogram significantly reduced their risk of death and having another heart attack at 30 days with the medication fondaparinux, without an increased risk of bleeding and strokes

15 Mar 2006

Use of high humidity does not improve symptoms of croup

For children with moderate to severe croup treated in the emergency department, use of high humidity did not improve symptoms more than low humidity or mist therapy, according to an article in the March 15 issue of JAMA: The Journal of the American Medical Association.

15 Mar 2006

Intensive statin therapy shows promise for inducing regression of coronary atherosclerosis

Patients treated with very intensive statin therapy lowered LDL-C levels on average by about 50 percent, increased HDL-C levels by 15 percent, and showed regression of coronary atherosclerosis

15 Mar 2006